Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?Jingmei Hsu, Koen van Besien, Ellen K. Ritchie et al.|Transplantation and Cellular Therapy|2019Cited by 3
Does Presence of Persistent Molecular Mutations Matter in AML Patients Undergoing Allogeneic Stem Cell Transplant?Sang‐Min Lee, Koen van Besien, Jingmei Hsu et al.|Blood|2018Cited by 1
Impact of Peri-Transplant Molecular Mutations on Outcomes of AML Patients Undergoing Fludarabine/Melphalan Conditioned Allogeneic Stem Cell TransplantMateo Mejía Saldarriaga, Jingmei Hsu, Yassine Tahri et al.|Blood|2021Cited by 0
Impact of Peri-Transplant Molecular Mutations Onoutcomes of AML Patients Undergoing Fludarabine/ Melphalan Conditioned Allogeneic Stem Cell TransplantMateo Mejía Saldarriaga, Jingmei Hsu, Yassine Tahri et al.|Transplantation and Cellular Therapy|2022Cited by 0